Tmunity raises $100M series A

T cell immunotherapy company Tmunity Therapeutics Inc. (Philadelphia, Pa.) raised $100 million in a series A round Tuesday from new investors Ping An Ventures, Parker Institute for Cancer Immunotherapy, Gilead

Read the full 306 word article

User Sign In